The FDA announced on Monday the full approval of the Pfizer vaccine for those 16 and older. That means the vaccine has now undergone extensive review over a substantial period of time —more than six months —to ensure long-term safety, said Dr. Prathit Kulkarni, with infectious diseases at Baylor College of Medicine. A fully approved…Continue...KEEP READING